Answers are grounded in this paper and cite their sources.
Recently, this journal published a paper from Marr et al 1 concerning multi-drug intra-arterial chemotherapy (IAC) for intraocular retinoblastoma. In many centres IAC has quickly garnered exciting interest, emerging as a promising, highly effective alternative for globe conserving treatment.2–4 In our institution, IAC with melphalan (IACM) has been performed since June 2008, and topotecan was added in June 2011. Fifty-nine patients have at least 1 year follow-up. Here we report our results obtained with IACM.
No takes yet. Share an insight, caveat, or question.
Bracco et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: